Bioengineering & Translational Medicine, 2016 · DOI: 10.1002/btm2.10018 · Published: January 1, 2016
The spinal cord's inability to regenerate after injury is primarily due to an inflammatory response that hinders growth, leading to further damage and cell death. The study focuses on reducing this inflammation by promoting a shift in immune cells towards anti-inflammatory types. The research uses multiple-channel bridges to deliver a virus encoding IL-10, an anti-inflammatory factor, directly to the injured area. This approach aims to locally modify the inflammatory response and create a more supportive environment for nerve regeneration. The study found that localized delivery of IL-10 modulated the immune response, reducing neutrophil infiltration and skewing macrophages toward an anti-inflammatory phenotype, ultimately improving motor function in the injured mice.
Localized IL-10 delivery could serve as a promising therapeutic strategy to reduce inflammation and promote regeneration after spinal cord injury.
IL-10 delivery can be combined with other regenerative strategies, such as neurotrophic factors, to enhance axon regeneration and functional recovery.
The use of PLG bridges and lentiviral vectors presents a translatable approach, as both components have been used in clinical applications.